Changes in these extra-skeletal leptin target organs in the leptin signaling-deficient state can influence bone metabolism due to hypogonadism, elevated corticosteroid levels, type 2 diabetes, sarcopenia, impaired thermoregulation, and/or greatly increased body weight [19,20,21]. This evidence concerns the gene LEP and sarcopenia.